glp 1 receptor agonists in idiopathic intracranial hypertension Treatment with GLP-1 is associated with significant weight loss and favorable headache outcomes | The Journal of Headache and Pain Use of glucagon-like peptide-1 receptor
Description
They have also been linked to more serious issues like thyroid cancer, pancreatitis, and gallbladder problems
It is also not recommended for patients with existing gastrointestinal disease to avoid potential side effects or exacerbating the condition
AMG 133 Phase I results Are GLP-1 Weight Loss Drugs the Next Blockbusters
Its important to note that its generally not recommended for women to take GLP-1s or other weight loss medications while looking to get pregnant, are currently pregnant, or are breastfeeding
Compare and Contrast the Glucagon-Like Peptide-1 Receptor Agonists (GLP1RAs)
Liraglutide and semaglutide are available in the UK and the U.S
